Skip to Content

753 (Temozolomide 100 mg)

Pill with imprint 753 is Pink & White, Capsule-shape and has been identified as Temozolomide 100 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 753

Temozolomide

Imprint
753
Strength
100 mg
Color
Pink & White
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0753
Inactive Ingredients
lactose anhydrous, sodium starch glycolate type B potato, tartaric acid, stearic acid, butyl alcohol, alcohol, ferrosoferric oxide, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, ammonia, water, gelatin, titanium dioxide, sodium lauryl sulfate, FD&C Red No. 3, D&C Yellow No. 10, silicon dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "753"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.